Holen Sie sich die Stockscreener-App
6.15
3.65%
0.27
Schlusskurs vom Vortag:
$5.88
Offen:
$5.87
24-Stunden-Volumen:
72,042
Relative Volume:
0.56
Marktkapitalisierung:
$4.13M
Einnahmen:
$49,300
Nettoeinkommen (Verlust:
$-6.27M
KGV:
-0.6766
EPS:
-9.09
Netto-Cashflow:
$-5.38M
1W Leistung:
-15.00%
1M Leistung:
-15.70%
6M Leistung:
-14.52%
1J Leistung:
+29.73%
1-Tages-Spanne:
$5.71
$6.3242
1-Wochen-Bereich:
$5.71
$8.09
52-Wochen-Spanne:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Vergleichen Sie ACON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
6.148 | 3.95M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
232.04 | 39.30B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.27 | 13.71B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.65 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.25 | 7.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.35 | 6.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq
Can Aclarion Inc. Equity Warrant stock maintain growth trajectory2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Aclarion Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Will Aclarion Inc. stock deliver better than expected guidance2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Aclarion’s Nociscan featured in special pain issue of spine journal By Investing.com - Investing.com Nigeria
Is Aclarion Inc. (IT20) stock vulnerable to rate hikes2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
How Aclarion Inc. (IT20) stock gains from tech spendingMarket Performance Recap & Weekly Stock Performance Updates - Newser
Why Aclarion Inc. (IT20) stock stays resilientJuly 2025 Decliners & Target Return Focused Picks - Newser
How sustainable is Aclarion Inc. Equity Warrant stock dividend payout2025 Market Trends & Detailed Earnings Play Alerts - Newser
Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication - Quiver Quantitative
Aclarion stock rises after feature in special pain issue of spine journal By Investing.com - Investing.com South Africa
Aclarion stock rises after feature in special pain issue of spine journal - Investing.com Canada
Aclarion’s Nociscan featured in special pain issue of spine journal - Investing.com
Aclarion announces publication of Nociscan article in pain issue of IJSS - TipRanks
Aclarion's Nociscan Featured in International Journal of Spine Surgery's Special Pain Issue, Highlighting Advances in Chronic Low Back Pain Diagnosis - Quiver Quantitative
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) - Yahoo Finance
Can Aclarion Inc. (IT20) stock sustain double digit ROEJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Is Aclarion Inc. (IT20) stock suitable for passive index fundsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Will Aclarion Inc. (IT20) stock sustain uptrend momentumQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Will Aclarion Inc. stock remain a Wall Street favoriteIPO Watch & Target Return Focused Stock Picks - Newser
Aug Intraday: Will QRAFT AI Enhanced U.S. Large Cap stock return to pre crash levelsJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Will Aclarion Inc. Equity Warrant stock reach Wall Street targets2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
How Aclarion Inc. stock performs in high volatility marketsTrade Exit Report & Advanced Swing Trade Entry Plans - Newser
Will Aclarion Inc. (IT20) stock outperform energy sector in 20252025 Volatility Report & AI Powered Market Trend Analysis - Newser
Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S - marketscreener.com
Aclarion, Inc. (ACON) 15.7% in Intraday Trading: Appointment of Commercial Director Drives Interest - Stocks Telegraph
Aclarion appoints Jason Brosniak as commercial director, Eastern U.S. - TipRanks
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - Yahoo Finance
Is Aclarion's Debt-Free Position The Backbone Of Its Next Phase Of Expansion? - RTTNews
2 innovative micro-cap stocks for 2026 - MSN
2 innovative micro-cap stocks for 2026 | 2025-12-01 | Investing News - Stockhouse
Is Aclarion Inc Equity Warrant a good long term investmentEarnings Forecast Updates & Affordable Growth Investments - earlytimes.in
Momentum Shift: Why Aclarion Inc. stock appeals to dividend seekersQuarterly Risk Review & Precise Buy Zone Identification - BỘ NỘI VỤ
Can Aclarion Inc. stock hit record highs againInflation Watch & Fast Moving Market Watchlists - BỘ NỘI VỤ
What margin trends mean for Aclarion Inc. stockMarket Activity Summary & Free Long-Term Investment Growth Plans - BỘ NỘI VỤ
Aclarion loss widens, but balance sheet remains strong - BizWest
Is Aclarion Inc a good long term investmentLarge Cap Stability Picks & Access Our Free Weekly Investment Letter - earlytimes.in
Critical Review: Aclarion (ACON) vs. The Competition - Defense World
Aclarion Inc. (ACON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Aclarion Inc. (IT20) stock stays on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com
Is Aclarion Inc. Equity Warrant stock trading near support levels2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Positive Outlook on Aclarion, Inc. Driven by Revenue Growth and Strategic Investments - TipRanks
Ascendiant Capital Maintains Aclarion (ACON) Buy Recommendation - Nasdaq
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Aclarion (ACON) Sees Price Target Boost by Ascendiant Capital | - GuruFocus
How interest rate cuts could boost Aclarion Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Aclarion (ACON) versus Its Rivals Head to Head Review - Defense World
How Aclarion Inc. stock compares to industry benchmarksLong Setup & Detailed Earnings Play Alerts - newser.com
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):